The website discusses a new clinical guideline that links care for heart, kidney, and metabolic diseases under the CKM syndrome framework, highlighting its prevalence and the need for coordinated care.
The claims regarding the CKM syndrome and related guidelines are largely supported by multiple sources. The claim about the prevalence of CKM syndrome in the US is strongly corroborated by data from reputable sources like PubMed and Renal and Urology News. The introduction of the CKM framework by the American Heart Association in 2023 is also well-supported. The claim about obesity and overweight affecting over 70% of the US population is confirmed by sources such as The Lancet. The development of the guideline by the American Heart Association and other organizations is verified by multiple authoritative sources. However, the claim about a new clinical guideline linking care for heart, kidney, and metabolic diseases lacks specific evidence, resulting in a lower score for that claim.
June 11, 2026Language: en5 claims analyzed
Individual Claims
31
Mostly False
Health
A new clinical guideline links care for heart, kidney, and metabolic diseases.
No specific evidence was found directly confirming the existence of a new clinical guideline linking care for heart, kidney, and metabolic diseases. The available evidence discusses various clinical guidelines but does not specifically mention a new guideline linking these three areas. Therefore, the claim remains unverified.
Fact Check ScoreNone
Fact Check Weight0
Web Consensus ScoreNone
Web Consensus Weight50
Source Quality Score50
Source Quality Weight25
Llm Reasoning Score50
Llm Reasoning Weight25
Weighted Total31
Evidence SummaryNo specific evidence found confirming the claim.
84
True
Health
Nearly 90 percent of adults in the United States met criteria for one of the stages of CKM syndrome as of 2020.
Multiple sources, including PubMed and Renal and Urology News, confirm that approximately 90% of US adults meet criteria for one of the stages of CKM syndrome. This is based on data from the National Health and Nutrition Examination Survey (NHANES) from 2011-2020.
Fact Check ScoreNone
Fact Check Weight0
Web Consensus Score90
Web Consensus Weight50
Source Quality Score90
Source Quality Weight25
Llm Reasoning Score90
Llm Reasoning Weight25
Weighted Total84
Evidence SummaryMultiple sources confirm the prevalence of CKM syndrome in the US.
The CKM syndrome framework was introduced in a 2023 American Heart Association advisory.
Evidence from multiple sources, including Brigham Health and Renal and Urology News, confirms that the American Heart Association introduced the CKM syndrome framework in 2023. This framework addresses the interrelatedness of heart disease, kidney disease, and metabolic disorders.
Fact Check ScoreNone
Fact Check Weight0
Web Consensus Score95
Web Consensus Weight50
Source Quality Score95
Source Quality Weight25
Llm Reasoning Score95
Llm Reasoning Weight25
Weighted Total89
Evidence SummaryMultiple sources confirm the introduction of the CKM framework by AHA in 2023.
Obesity and overweight are impacting over 70 percent of the population in the United States.
Evidence from sources like The Lancet and Wikipedia confirms that over 70% of the US population is affected by obesity and overweight. The obesity rate alone is reported to be around 42.4%, with a significant portion of the population also being overweight.
Fact Check ScoreNone
Fact Check Weight0
Web Consensus Score85
Web Consensus Weight50
Source Quality Score85
Source Quality Weight25
Llm Reasoning Score85
Llm Reasoning Weight25
Weighted Total79
Evidence SummaryMultiple sources confirm the high prevalence of obesity and overweight in the US.
The guideline was developed by the American Heart Association, the American College of Cardiology, the American Diabetes Association, and the American Society of Nephrology.
Multiple sources, including the American College of Cardiology and Cardiovascular Business, confirm that the guideline was developed by the American Heart Association, the American College of Cardiology, and endorsed by the American Diabetes Association and the American Society of Nephrology.
Fact Check ScoreNone
Fact Check Weight0
Web Consensus Score95
Web Consensus Weight50
Source Quality Score95
Source Quality Weight25
Llm Reasoning Score95
Llm Reasoning Weight25
Weighted Total89
Evidence SummaryMultiple sources confirm the development of the guideline by the mentioned organizations.